Literature DB >> 6979417

Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.

B Rafnar.   

Abstract

Of 730 Icelandic schoolgirls, 12 years of age, screened for rubella antibodies by the haemagglutination-inhibition (HI) technique, 372 (50.9%) were found to be seronegative. Rubella vaccine was administered to 355 members of this group, and to 12 girls with an HI titre of 20. Blood samples were taken 6 weeks and 1 year after immunization from 336 previously seronegative girls and from the 12 low-positive vaccinees, and tested for HI antibodies. The seroconversion rate was 99.15%. One year after immunization, 94.8% of the girls tested had an HI antibody titre of 40 or more. The geometric mean titre (GMT) of the previously seronegative girls was 62.07 at 6 weeks and 61.69 at one year after vaccination. Of the girls with an initially low positive titre, only 3 (25%) showed a significant rise. The GMT was 40 at 6 weeks, but fell to 25.2 after 1 year. Re-immunization had no effect on antibody levels in either group.A severe rubella epidemic occurred 2 years after immunization, following which 345 vaccinees and 193 naturally immune controls were studied. All subjects had been exposed to wild rubella virus at school, and rubella cases had occurred in the homes of 116 vaccinees (33.6%) and 41 control subjects (21.2%). Only 5 (1.5%) primarily seronegative vaccinees and 2 unimmunized controls (1%) showed serological evidence of infection during the epidemic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979417      PMCID: PMC2536011     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.

Authors:  A Schluederberg; D M Horstmann; W A Andiman; M F Randolph
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

2.  Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.

Authors:  L Grillner
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

3.  Follow-up on rubella vaccinations and experience with subclinical reinfection.

Authors:  J D Farquhar
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

4.  Direct HIG test for rubella antibodies.

Authors:  B Einarsdóttir; B Rafnar
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

5.  Controlling rubella: problems and perspectives.

Authors:  D M Horstmann
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

  5 in total
  1 in total

1.  Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females.

Authors:  S Gudmundsdóttir; A Antonsdóttir; S Gudnadóttir; S Elefsen; B Einarsdóttir; O Olafsson; M Gudnadóttir
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.